Published in Law and Health Weekly, October 14th, 2006
Study 1: Renal cell carcinoma (RCC) could be linked to high alpha-methyl CoA racemase (AMACR) expression.
"AMACR, a new molecular marker for prostate cancer, has been recently reported to be one of the most highly expressed genes in papillary RCCs. We tested the diagnostic usefulness of AMACR antibody in a series of 110 renal tumors: 53 papillary RCCs (33 type 1, 20 type 2); 25 conventional RCCs; 6 chromophobe RCCs; 9 oncocytomas; 5 mucinous tubular and spindle tumors; 2 urothelial carcinomas; 7 angiomyolipomas; and 2 Bellini carcinomas," scientists writing in the journal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.